Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation.

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation. — المؤلف: Ha, Boram — Radiation oncology (London, England) 20190201

المؤلف
Ha, Boram
النشر
Radiation oncology (London, England) 20190201
الوصف
4 p.
الموضوعات
Adenocarcinoma؛ Adult؛ Aged؛ Aged, 80 and over؛ Dose Fractionation, Radiation؛ Follow-Up Studies؛ Humans؛ Male